Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infrared Fluorescent Agent

BACKGROUND: Near-infrared (NIR) fluorescence is a promising novel imaging technique that can aid in intraoperative demarcation of pancreatic cancer (PDAC) and thus increase radical resection rates. This study investigated SGM-101, a novel, fluorescent-labeled anti-carcinoembryonic antigen (CEA) anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoogstins, Charlotte E. S., Boogerd, Leonora S. F., Sibinga Mulder, Babs G., Mieog, J. Sven D., Swijnenburg, Rutger Jan, van de Velde, Cornelis J. H., Farina Sarasqueta, Arantza, Bonsing, Bert A., Framery, Berenice, Pèlegrin, André, Gutowski, Marian, Cailler, Françoise, Burggraaf, Jacobus, Vahrmeijer, Alexander L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Pancreatic Tumors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132431/
https://www.ncbi.nlm.nih.gov/pubmed/30051369
http://dx.doi.org/10.1245/s10434-018-6655-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132431/
https://www.ncbi.nlm.nih.gov/pubmed/30051369
http://dx.doi.org/10.1245/s10434-018-6655-7

Ejemplares similares